Zhejiang Conba Pharmaceutical's controlling shareholder plans to increase its holdings of the company's shares by 1.999%.

Zhejiang Conba Pharmaceutical (600572.SH) announced that based on its firm confidence in the company's development prospects, recognition of the long-term investment value of the company, and the need to further enhance its control, the company's controlling shareholder Zhejiang Medicine Group plans to increase its holdings of the company's shares through block trading on the Shanghai Stock Exchange within 3 months after 15 trading days from the date of the announcement. The planned increase in shares is 50.65 million shares, accounting for 1.999% of the company's current total share capital. The second largest shareholder of the company, Zhejiang Conba Pharmaceutical Group Co., Ltd. ("Zhejiang Conba Pharmaceutical Group"), is the block trading transferor in this transaction for Zhejiang Medicine Group's increased shareholding.